Published in Int J Cancer on November 01, 2006
A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 2.56
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One (2008) 2.13
Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol (2010) 1.64
The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res (2011) 1.48
Association between Streptococcus bovis and colon cancer. J Clin Microbiol (2009) 1.29
Streptococcus bovis: causal or incidental involvement in cancer of the colon? Int J Cancer (2006) 1.20
Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev (2008) 1.18
Complete genome and comparative analysis of Streptococcus gallolyticus subsp. gallolyticus, an emerging pathogen of infective endocarditis. BMC Genomics (2011) 1.14
Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer (2010) 1.12
Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report. World J Surg Oncol (2008) 1.06
Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci (2013) 1.02
Surface-exposed histone-like protein a modulates adherence of Streptococcus gallolyticus to colon adenocarcinoma cells. Infect Immun (2009) 0.95
Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients. Cancer (2010) 0.89
Smoking and other personal characteristics as potential predictors for fecal bacteria populations in humans. Med Sci Monit (2010) 0.86
Correlation among Streptococcus bovis, endocarditis and septicemia in a patient with advanced colon cancer: a case report. J Med Case Rep (2013) 0.83
Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients. Cancer Prev Res (Phila) (2011) 0.82
Species diversity and relative abundance of lactic acid bacteria in the milk of rhesus monkeys (Macaca mulatta). J Med Primatol (2010) 0.81
Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? Infect Agent Cancer (2012) 0.80
Gut microbiota, inflammation and colorectal cancer. Genes Dis (2016) 0.79
Significant Association of Streptococcus bovis with Malignant Gastrointestinal Diseases. Int J Microbiol (2011) 0.77
Streptococcus bovis endocarditis and colon cancer: myth or reality? A case report and literature review. BMJ Case Rep (2012) 0.76
Analysis of Pseudomonas aeruginosa cell envelope proteome by capture of surface-exposed proteins on activated magnetic nanoparticles. PLoS One (2012) 0.75
Gestational choriocarcinoma complicated by infective endocarditis during chemotherapy. Gynecol Oncol Rep (2017) 0.75
Causal role of infectious agents in cancer: An overview. Caspian J Intern Med (2017) 0.75
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18
Many sequence variants affecting diversity of adult human height. Nat Genet (2008) 12.80
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2007) 10.81
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2008) 7.65
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest (2005) 4.84
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res (2002) 3.78
Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology. Cell (2005) 3.77
MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol (2006) 3.05
Evaluation of intraperitoneal pressure and the effect of different osmotic agents on intraperitoneal pressure in children. Perit Dial Int (2005) 2.74
Hepcidin: from discovery to differential diagnosis. Haematologica (2008) 2.69
Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem (2007) 2.41
Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum (2011) 2.38
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32
Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis (2011) 2.05
Characterization of lysine 56 of histone H3 as an acetylation site in Saccharomyces cerevisiae. J Biol Chem (2005) 1.95
Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics (2010) 1.92
Universal features of post-transcriptional gene regulation are critical for Plasmodium zygote development. PLoS Pathog (2010) 1.90
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis (2011) 1.74
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant (2002) 1.74
Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat (2002) 1.70
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol (2010) 1.66
Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis (2009) 1.63
The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J Cell Biol (2008) 1.63
Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis (2004) 1.58
Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis (2007) 1.51
The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion (2008) 1.51
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Hepcidin in human iron disorders: diagnostic implications. Clin Chem (2011) 1.50
Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem (2005) 1.48
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma (2013) 1.47
Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica (2010) 1.47
Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. J Gerontol A Biol Sci Med Sci (2010) 1.45
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood (2008) 1.43
TRPM7 regulates myosin IIA filament stability and protein localization by heavy chain phosphorylation. J Mol Biol (2008) 1.32
(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem (2009) 1.30
A novel iterative method for lesion delineation and volumetric quantification with FDG PET. Nucl Med Commun (2007) 1.27
Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. J Biol Chem (2007) 1.24
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant (2009) 1.22
Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol (2008) 1.19
Massive autophosphorylation of the Ser/Thr-rich domain controls protein kinase activity of TRPM6 and TRPM7. PLoS One (2008) 1.19
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol (2009) 1.19
Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab (2009) 1.18
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. Anal Biochem (2005) 1.16
CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet (2012) 1.16
The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1. J Mol Biol (2002) 1.14
Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One (2012) 1.12
Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant (2008) 1.10
Shedding & shaving: disclosure of proteomic expressions on a bacterial face. Proteomics (2008) 1.09
Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol (2003) 1.09
The alpha-kinases TRPM6 and TRPM7, but not eEF-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC. FEBS Lett (2008) 1.07
Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice. PLoS One (2009) 1.07
In vitro targeting reveals intrinsic histone tail specificity of the Sin3/histone deacetylase and N-CoR/SMRT corepressor complexes. Mol Cell Biol (2004) 1.07
An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One (2008) 1.06
The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab (2009) 1.06
A novel immunological assay for hepcidin quantification in human serum. PLoS One (2009) 1.05
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol (2010) 1.05
Training surface and intensity: inflammation, hemolysis, and hepcidin expression. Med Sci Sports Exerc (2009) 1.04
Iterative orthology prediction uncovers new mitochondrial proteins and identifies C12orf62 as the human ortholog of COX14, a protein involved in the assembly of cytochrome c oxidase. Genome Biol (2012) 1.03
Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells. Cancer Res (2011) 1.03
RACK1 inhibits TRPM6 activity via phosphorylation of the fused alpha-kinase domain. Curr Biol (2008) 1.03
Cumulative effects of consecutive running sessions on hemolysis, inflammation and hepcidin activity. Eur J Appl Physiol (2009) 1.03
Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr (2009) 1.02
Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol (2003) 1.01
The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. J Proteomics (2012) 1.01
Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One (2011) 1.00
High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion (2012) 1.00
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol (2009) 0.99
Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant (2011) 0.99
The effects of carbohydrate ingestion during endurance running on post-exercise inflammation and hepcidin levels. Eur J Appl Physiol (2011) 0.98
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. Blood (2011) 0.98
Effects of exercise on hepcidin response and iron metabolism during recovery. Int J Sport Nutr Exerc Metab (2009) 0.98
Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. Eur J Heart Fail (2010) 0.97
A feed-forward repression mechanism anchors the Sin3/histone deacetylase and N-CoR/SMRT corepressors on chromatin. Mol Cell Biol (2006) 0.96
Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol (2012) 0.96
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1. Haematologica (2013) 0.96
Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res (2002) 0.96
Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev (2014) 0.96
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl) (2011) 0.95
An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells. J Leukoc Biol (2010) 0.95
Surface-exposed histone-like protein a modulates adherence of Streptococcus gallolyticus to colon adenocarcinoma cells. Infect Immun (2009) 0.95
Effect of exercise modality and intensity on post-exercise interleukin-6 and hepcidin levels. Int J Sport Nutr Exerc Metab (2012) 0.94
Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant (2012) 0.93
Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut. Cell Host Microbe (2013) 0.93
Effect of the new HJV-L165X mutation on penetrance of HFE. Blood (2007) 0.93
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS One (2012) 0.92
Extension of the binding motif of the Sin3 interacting domain of the Mad family proteins. Biochemistry (2004) 0.92
Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers. Hepatology (2013) 0.92
The effects of acute exercise bouts on hepcidin in women. Int J Sport Nutr Exerc Metab (2012) 0.92
Experimentally controlled downregulation of the histone chaperone FACT in Plasmodium berghei reveals that it is critical to male gamete fertility. Cell Microbiol (2011) 0.91
Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction? J Hepatol (2008) 0.90
Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency. J Cell Mol Med (2009) 0.90
Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist. Haematologica (2009) 0.90